Jianxin shares: the net profit in 2021 is expected to decrease by 71% - 80% year-on-year
Financial Associated Press, Jan. 18 - Jianxin shares announced that it is expected to realize a net profit of 9-13 million yuan attributable to shareholders of Listed Companies in 2021, a year-on-year decrease of 71.37% - 80.18%. The sales price of the company's main products decreased significantly year-on-year, so the sales revenue and gross profit margin decreased, affecting the decrease of the company's net profit compared with the same period of last year.
This text is a result of machine translation.
Related companies：
Briefing Jun 10, 2022 08:44 AM
· Technology
SMIC International: received the ruling of the US court and rejected all civil actions against the company
In-depth
Healthcare
China's First Oral COVID-19 Antiviral Medicine in Dispute
An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.
Aug 08, 2022 09:00 AM
Jan 30, 2026 06:00 PM
Dec 11, 2023 08:49 PM
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Briefing Apr 26, 2022 06:34 PM
· Technology
Anjie Technology: net profit in the first quarter increased by 1788% year-on-year
Healthcare
Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps
Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.
Apr 27, 2022 10:55 PM
Insight
Briefing Feb 17, 2022 10:08 AM
Yingsi intelligence and Fosun Pharmaceutical reached the first milestone of strategic cooperation: nomination and targeting cd47-sirp α Small molecule compounds of signal pathway
See more
Read next
Insight
In-depth
Technology · Interview
Exclusive Interview: NAVEE GOLF Is Building a Smart Golf Ecosystem, Starting with Push Carts
Yesterday 05:04 PM
Insight
In-depth
Embodied AI · Analysis
Chinese Embodied AI Company AI² Robotics: The Real Bottleneck in Embodied AI Is Scenarios, Not Just AI
Apr 14, 2026 11:25 AM
Insight
In-depth
Technology, Embodied AI · Analysis
From 0 to 2.6 million units, Ecovacs Window Robot makes "first choice" the only answer.
Apr 10, 2026 07:00 PM
Insight
In-depth